| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  NuMedii NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases. Type: | 2 | 0 | 0 | 5 |
 | FairJourney Biologics Your trusted partner for innovative, end-to-end antibody services At FairJourney Biologics, we specialize in cutting-edge antibody discovery and development, offering end-to-end solutions that fast-track your research. With over a decade of expertise, our innovative technologies and seasoned team have successfully advanced 14 antibodies to clinical stages. Our adaptable partnership model empowers projects of any scale, fostering collaboration and breakthrough innovation. Whether you're in early-stage research or development, we deliver tailored, high-quality antibodies designed to meet your specific needs. Join us in revolutionizing therapeutic discovery and making lasting impacts on global healthcare. Monoclonal antibodies, Antibody humanization, Antibody production, Antibody affinity maturation, … Type: | 2 | 0 | 1 | 284 |
 | QMENTA Medical imaging software solutions that improve outcomes for research, and clinical trials QMENTA is a Medical Imaging AI tech company that offers cloud native software solutions for imaging professionals and imaging clinical trials through one single platform. Our customizable platform, QMENTA Imaging Hub, integrates 5 solutions in one single system: An Imaging Cloud, A Smart Uploader, AI Imaging Biomarkers, Central Review, and an Imaging Management System, (Imaging EDC, query management, project management and reporting) removing fragmentation, delays, human errors. With our global cloud-based infrastructure powered by quality data and AI technology, your research teams will be able to integrate any … Type: | 3 | 0 | 0 | 45 |
 | Dragonfly Therapeutics, Inc. Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas. For more information, email info@dragonflytx.com. immuno-oncology Type: | 4 | 0 | 1 | 124 |
 | AVROBIO Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring personalized gene therapy worldwide Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. … Type: | 3 | 1 | 0 | 58 |
 | Skyhawk Therapeutics We Use Small Molecules To Modify RNA Splicing Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that modify RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted toward cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com. Type: | 3 | 0 | 1 | 69 |
 |  Korro Bio, Inc. Edit the message. Rewrite the future. Pioneering RNA editing to deliver the future of medicine. Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body’s natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function, addressing the medical needs of patients. Our mission is to rewrite the future for patients living with debilitating disease by repairing the underlying genetic cause. Type: | 3 | 0 | 2 | 106 |
 | Apollomics We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies. Apollomics is an innovative biotechnology company committed to the discovery and development of oncology combination therapies. With operations in both the U.S. and China, we believe we are well positioned to unlock synergies by leveraging the strengths of partnerships with other biotechnology companies in the East and the West. Since our founding in 2015, under the leadership of our experienced management team with in-depth knowledge and expertise of the evolving cancer treatment landscape, we have built a pipeline of ten (10) drug candidates … Type: | 1 | 0 | 1 | 24 |
 | Poseida Therapeutics, Inc. The Capacity to Cure Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes investigational allogeneic CAR-T cell therapies for both solid tumors and hematologic cancers as well as investigational in vivo genetic medicines that address patient populations with high unmet medical need. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing. … Type: | 3 | 0 | 3 | 349 |
 | Civica Rx Serving patients is a privilege that comes with significant responsibilities. Civica Rx was created in late 2018 to secure the supply of important medicines hospitals use every day. As of Q2 2024, we have provided over 180 million units of essential medicines to hospitals, enough to help treat over 80 million patients. Recently, we announced we will manufacture and distribute affordable medications for consumers in an outpatient/retail setting, including affordable insulin. Insulin is an exciting project as we are partnering with nearly every corner of the diabetes ecosystem to bring low-cost insulin to people living with diabetes at no more … Type: | 1 | 0 | 0 | 188 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, … Type: | 7 | 0 | 1 | 446 |
 | Voyager Therapeutics, Inc. Breaking through barriers in gene therapy and neurology Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACERTM AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs … Type: | 3 | 0 | 2 | 200 |
 | Precigen Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of gene and cell therapies. Precigen: Advancing Medicine with PrecisionTM Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and … Type: | 0 | 0 | 0 | 114 |
 | Sen-Jam Pharmaceutical We’re changing the way the world treats inflammation and the way the pharma industry treats humanity Join the revolution! We’re changing the way the world treats inflammation and the way the pharma industry treats humanity. Invest today → https://wefunder.com/senjam Sen-Jam's Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. It's time for a stronger, more resilient world, free of side-effects and filled with living remarkably Inflammation , Wellbeing, Pain Relief, pharmaceutical, and healthcare Type: | 0 | 0 | 0 | 12 |
 | coIMMUNE, Inc. coIMMUNE is a privately held, clinical stage immune-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a novel CAR therapy that promises enhanced efficacy with greatly reduced toxicity. Type: | 5 | 2 | 3 | 8 |
 | InCarda Therapeutics Pioneering inhaled medications for cardiovascular conditions InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF). Cardiovascular, Inhalation therapy, Biotechnology, Pharmaceuticals, Clinical Development, Drug Formulation, Commercialization, Clinical Research, Pre-Clinical Research, and Regulatory Affairs Type: | 1 | 0 | 0 | 15 |
 | MindMed MindMed is a clinical-stage biopharma company developing novel products to treat brain health disorders MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the … Type: | 4 | 0 | 3 | 102 |
 | Unlearn.AI Advancing AI to eliminate trial and error in medicine. Advancing artificial intelligence to eliminate trial and error in medicine. Artificial Intelligence, Biotechnology, Pharmaceuticals, Machine Learning, Clinical Trials, Clinical Research, Computational Biology, Data Science, Biostatistics, Deep Learning, and Machine Learning Type: | 16 | 0 | 13 | 85 |
 |  American Gene™ A cell & #genetherapy company with a #gene delivery platform to develop cures to #cancer #HIV #PKU. In Phase 1 trial for #HIVcure. CEO @JeffreyGalvin. Type: | 1 | 0 | 0 | N/A |
 | Vir Biotechnology, Inc. Powering the Immune System to Transform Lives Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden. Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis … Type: | 7 | 1 | 3 | 588 |
 | Insmed Incorporated Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. We are dedicated to making a meaningful impact in patients’ lives as well as the communities where we live and work. Our team is guided by our core values of collaboration, accountability, passion, respect, and integrity. Insmed is headquartered in Bridgewater, NJ, and has offices and research locations throughout the United States, Europe, and Japan. We are proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending three consecutive years as … Type: | 3 | 0 | 2 | 1,185 |
 | Crinetics Pharmaceuticals Discovering drugs for endocrine diseases and endocrine-related tumors. #acromegaly #crinetics #CarcinoidSyndrome This place is about more than a pharmaceutical career. It’s about making a real difference in the lives of patients. That’s why we’re here. That’s why you should maybe think about being here, too. Our mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Working to accomplish this mission is how we bring our vision to life. For us, that vision is the best possible therapeutics available to all patients with diseases of … Type: | 3 | 0 | 1 | 355 |
 | The Concinnity Company The Clinical Trial Oversight Ecosystem. Simplified. Cloud Concinnity® is an integrated platform that centralizes, simplifies and automates control of data, communications, process management & reporting, while unlocking the value of big data. Our platform provides the most functional and comprehensive clinical trial oversight software on the market: a single, secure hub where all meetings, documents and processes can be centralized, automated, monitored and generate a complete audit trail. Cloud Concinnity enables developers of new therapies to bring their treatments to market faster, at a lower cost all while reducing risk to Sponsors, Clinical Research Organizations (CROs) and patients. software, clinical … Type: | 0 | 0 | 0 | 9 |
 | SoLongevity SoLongevity. Lifescience for HealthyAging SoLongevity promotes healthy ageing. How? By developing treatments and products, validated through solid clinical studies that aim to preserve what the World Health Organization has defined “physiological reserve”, that is the individual “capital-longevity” with which we are born and which constitutes the potential for health and wellbeing for the years to come. Our solutions are intended to allow each person to reach and maintain their maximum potential, preventing the risk conditions related to aging diseases. “Pathological” ageing is a phenomenon that is not only multifactorial but also articulated in a different and specific way for each … Type: | 0 | 0 | 0 | 10 |
 | BIOGARAN [Automatic translation follows] The box that takes care of you. French drug laboratory 🇫🇷 Biogaran was founded in 1996, to specifically respond to the development of a new, still little-known market: generic drugs. Offering patients quality drugs with recognized effectiveness whose patent had fallen into the public domain was then a new type of know-how that traditional laboratories did not possess. Our know-how is available through different ranges: from minor everyday ailments with the Biogaran Conseil® range, to more serious pathologies with prescription drugs. Whatever the pathology, patient health is at the heart of Biogaran's concerns and the same rigor … Type: | 10 | 3 | 6 | 535 |
 | Kayentis Simplify your clinical trial experience Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company … Type: | 7 | 5 | 3 | 162 |
 | Parfums Givenchy Hubert de Givenchy’s storied ascent to famed couturier began in 1952, when he opened the doors to his eponymous Parisian couture house. When Givenchy met Audrey Hepburn, he fell for her irresistible charm and youthful spirit. She informed Givenchy’s singular vision of “perfectly imperfect” beauty and inspired him to create his first fragrance, L’Interdit, made especially for her. The move into fragrances was a natural one for Givenchy, who considered his perfumes to be an extension of his couture, the elegance he wanted to give his clothes. He went on to release L’Interdit to the public in 1957 and followed … Type: | 5 | 2 | 1 | 23 |
 | ITERG French Institute for fats & related products: fats, vegetable oils, vegetable proteins and minor compounds. ITERG contributes to the development of the fats and related products industries: fats, vegetable oils and oil co-products, vegetable proteins and minor compounds derived from these products. ITERG provides companies with production, research and expertise skills and infrastructures. It contributes to the creation of value and the competitiveness of the industrial fabric, from upstream to downstream. CENTRE D'EXPERTISE SUR LES HUILES ET MATIERES GRASSES, EXPERTISE ANALYTIQUE ET NUTRITIONNELLE, PLATEFORME DE CHIMIE VERTE, UNITE DE RAFFINAGE DES HUILES, and PLATEFORME PROTEINES VEGETALES | 24 | 10 | 13 | 74 |
 | Caduceum [Automatic translation follows] Advice for #Health industries - Partner of Lifesciences Industries. #Pharmaceutical Caduceum is a 100% health consulting company! A specialized Life Sciences subsidiary of the ALTEN group, we work with pharmaceutical, biotechnology, medical device, cosmetic and nutri-health manufacturers. It is thanks to our 400 employees that we offer a specialist approach in all phases of industrial development, from product design to marketing and post-marketing. Our expertise extends over several areas: - Engineering - Industrialization - IT & Digital - Regulatory Affairs - Quality Assurance - R&D ... and Training through its Qualiopi-certified training platform: Caduceum Academy. Basic or … Type: | 9 | 2 | 5 | 336 |
 | Laboratoires Théa Théa, Let's Open Our Eyes Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries. Ophthalmology, Pharmaceuticals, Medical Devices, Eye care, Eye Health, and Preservative-free Type: | 11 | 6 | 5 | 811 |
 | Institut Universitaire Européen de la Mer (IUEM) [Automatic translation follows] The European University Institute of the Sea (IUEM) is a multidisciplinary organization in the field of marine and coastal sciences whose activities are centered around 3 missions: research, training and observation. The IUEM brings together seven laboratories (Joint Research Units associating UBO, CNRS, IRD, Ifremer and UBS) where nearly 500 researchers, teacher-researchers, engineers, technicians and permanent and contract administrative staff work. An internal school of the University of Western Brittany (UBO), the IUEM offers within the Marine and Coastal Sciences (SML) training area, eight master's courses very closely associated with its laboratories and also houses the Doctoral … Type: | 24 | 7 | 6 | 112 |
 | OZ Biosciences OZ Biosciences creates, develops and commercializes life sciences reagents specialized in transfection and transduction OZ Biosciences is a product development company that creates, develops and commercializes delivery systems of bioactive materials (DNA, siRNA, proteins, antibodies...), intended for the worldwide scientific community and pharmaceutical industries. Our mission is to assist scientists to accelerate the rhythm of discoveries by offering them technologically advanced tools such as transfection reagents and other life science research products. Principal innovations are based on propietary technologies such as Magnetofection (magnetic-assisted transfection or infection), Magneto-Biolistic, transfection reagents, transduction tools, mRNA and lipids-based delivery systems (LNP). Specialized and expert … Type: | 3 | 1 | 2 | 18 |
 | genOway Together, we science better Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom … Type: | 5 | 3 | 1 | 109 |
 | ACAVI - Talent Acquisition Partner Management des Ressources Humaines ACAVI est une société spécialisée en Executive Search et Recrutement, Assessment spécialisé et Conseil stratégique et opérationnel dédié au Top et Middle Management des entreprises et structures académiques du secteur des Sciences de la Vie, la Chimie et les Matériaux. ACAVI est positionné en France et dans le monde comme Leader expert des métiers à forte valeur ajoutée de la Recherche, Développement, Industrialisation, Réglementaire, Qualité, Commercial, Marketing et Service. ACAVI is a company specialized in Executive Search and Recruitment, Assessment and Strategic and Operational Consulting dedicated to the Top and Middle Management for companies and academic … | 0 | 0 | 0 | 17 |
 | Filière Intelligence Artificielle & Cancers [Automatic translation follows] Transforming data into tangible innovations. The "Filière Intelligence Artificielle & Cancers" Association was created on August 3, 2021. It is the result of an unprecedented public-private partnership and brings together representatives from the National Cancer Institute, the Health Data Hub, the Alliance for Research and Innovation in Health Industries, France Biotech and nine of the world's largest healthcare manufacturers in oncology: Amgen, AstraZeneca, Bristol-Myers Squibb, Janssen, MSD, Novartis, Pfizer, Pierre Fabre and Roche diagnostic. Its ambition is to address, through all the data available in France, questions that bring value to patients and are transformed into tangible … Type: | 9 | 3 | 7 | 8 |
 | ScienceOne AI-Powered Professional Platform for Life Sciences AI-Powered Professional Platform for Life Sciences Promote and interconnect talented people and organization with Life Sciences ScienceOne is a dynamic and innovative organization that is at the forefront of scientific research and development. Our mission is to drive breakthroughs in technology, medicine, and engineering through collaboration and knowledge sharing. As ScienceLeadR.eu, we aim to connect scientists, researchers, and industry leaders to foster collaborations and accelerate the pace of scientific discovery. Join us to be part of a community that is shaping the future of science. santé, Health, biotech, healthtech, medtech, drugs, healthcare, health experts, … Type: | 16 | 2 | 16 | 7 |
 | FenoMark Diagnostics AB Dedicated to the discovery and development of biomarkers lung cancer patients Dedicated to improving cancer care by developing better diagnostic assays for therapy selection. diagnostics, cancer, proteomics, lung cancer, and biomarkers | 1 | 0 | 0 | 2 |
 | Epigenica Bringing the first multiplex, high-throughput tools to epigenomic research Epigenica is a life sciences technology company at the forefront of innovations in epigenetic research. The company’s EpiFinder platform enables researchers to perform comprehensive epigenetic studies at unprecedented speed, scalability, and affordability. Epigenica is building a portfolio of products based on the EpiFinder platform to offer comprehensive high-throughput profiling at different depths of detail with an array of possible starting materials. The platform is powered by the company’s patented and proprietary high-throughput, multiplex, quantitative ChIP-seq technology (hmqChIP), the first commercial kit of its kind. With the advantages of the EpiFinder platform, … Type: | 6 | 0 | 1 | 13 |
 | Weleda France [Automatic translation follows] #Focus_GrowthThatMatters * * Growth that makes sense Nature is our source of inspiration. Faithful to this fundamental principle since 1921, we offer products exclusively derived from nature: homeopathic and phytotherapeutic medicines as well as cosmetic care. All our energy and know-how are mobilized to develop biodiversity, care for the soil, preserve the vitality of plants, draw with respect from the diversity of nature and transmit its healing virtues to human beings. | 5 | 2 | 2 | 144 |
 | SingCell A stem cells Contract Development and Manufacturing Organisation (CDMO) in Singapore. MSC, iPSC, clean meat. SingCell offers process development and contract manufacturing services for stem cell therapy and clean meat companies. SingCell leverages its proprietary technology to improve manufacturing processes and offer high consistent quality stem cells. #cleanmeat #celltherapy Type: | 0 | 0 | 0 | 1 |
 | CollPlant Pioneering Regenerative Medicine CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics. Our mission at CollPlant is to deliver ground-breaking … Type: | 1 | 0 | 0 | 72 |
 | INFORS HT Incubation shakers, bioreactors and bioprocess software for reliable and efficient cultivations. INFORS HT is your specialist for bioreactors, incubation shakers and bioprocess control software for reliable and efficient cultivations. You benefit from sophisticated systems, in which your cell lines or microorganisms develop their full potential in a reproducible way, thus contributing to your success. For your applications, we offer the right solutions: Fermentation of microorganisms (bacteria, fungi and yeasts) Cell culture (mammalian cells, insect cells, plant cells and algae) Biofuel (biodiesel and bioethanol) Parallel bioprocesses Custom-made bioreactors and incubation shakers Bioprocess control software Qualification of bioreactors and incubation shakers Closeness … Type: | 1 | 0 | 1 | 170 |
 | The Breast Cancer Research Foundation The highest-rated breast cancer org in the U.S. We fund research to find a cure in our lifetime. BCRF is the highest-rated breast cancer organization in the U.S. We provide critical funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship. Since our founding in 1993 by Evelyn H. Lauder, BCRF has raised more than half a billion dollars for lifesaving research. Through a unique and streamlined grants program, we seek out the brightest minds in science and medicine and give them the necessary resources to pursue their best ideas. As a result, … | 10 | 4 | 11 | 90 |
 | Fraunhofer ISST #InnovationsFromData #dataspaces #industrialmanufacturing #healthcare #smartcities #itserviceproviders The »Fraunhofer-Institut für Software- und Systemtechnik ISST« (Fraunhofer Institute for Software and Systems Engineering) develops data space technologies for sovereign data exchange and builds pioneering data ecosystems with its partners. The institute is located in Dortmund / Germany. It is part of the »Fraunhofer-Gesellschaft e.V.« the biggest corporation for applied research in Europe. Together with companies, the Fraunhofer Institute for Software and Systems Engineering ISST identifies the strategic value of their data and makes it usable - from data preparation to the development of new business models, the institute offers complete system solutions. In … Type: | 23 | 5 | 15 | 149 |
 | NeuroClin Ltd NeuroClin Glasgow - pioneering neuro clinical research in Alzheimer’s, Dementia, Parkinson's and Depression. NeuroClin Glasgow is an independent research organisation dedicated to pioneering new research and treatments for Memory Impairment, Alzheimer's, Dementia, Parkinson's, Depression and other neurological conditions. We aim to help and support those who have a wide range of memory difficulties and to ensure the highest standards of care and attention for those participating in our research programmes. We are the only centre in Scotland which has conducted research on all of the currently licensed treatments for Alzheimer’s disease. Research and Clinical Trials Type: | 0 | 0 | 0 | 41 |
 | Signant Health The Evidence Generation Company Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. Learn more at www.signanthealth.com. clinical trial software, eCOA, eConsent, IRT, Clinical Supply Optimization, Patient Engagement, Rater Training, Data … Type: | 12 | 2 | 8 | 2,077 |
 | RELIEF THERAPEUTICS Holding SA Providing relief to patients with unmet medical needs in select specialty and rare diseases. RELIEF THERAPEUTICS Holding SA (SIX: RLF; OTCQB: RLFTF, RLFTY) We are a biopharmaceutical company committed to providing therapeutic relief to patients living with rare diseases. Our goal is to advance treatment paradigms and deliver improvements in efficacy, safety and convenience to benefit the lives of patients and their families. Our therapeutic focus is on rare indications for metabolic disorders, pulmonary diseases, and dermatology/connective tissue disorders. Acute Lung Injury, Pulmonary Sarcoidosis, Lung Fibrosis, Acute Respiratory Distress Syndrome, Urea Cycle Disorders, Maple Syrup Urine Disease, Rare Diseases, Epidermolysis … Type: | 0 | 0 | 0 | 10 |
 | Fundación Recal [Automatic translation follows] An open door to recovery. The Recal Foundation is a centre specialising in the treatment of alcoholism, addiction to all drugs, but also to behaviours such as gambling, internet, shopping, food (bulimia, binge eating, food cravings and/or compulsive eating) or sex. Effective interventions are also offered for the treatment of smoking. We have a team of: Psychiatrists, Doctors, Nurses, Psychologists and Therapists. Addiction treatment Type: | 1 | 1 | 0 | 27 |
 | EveryLife Foundation for Rare Diseases The EveryLife Foundation for Rare Diseases educates, supports and amplifies the voice of rare disease patient advocates. We empower the rare disease patient community to advocate for impactful, science-driven legislation and policy that advances the equitable development of and access to lifesaving diagnoses, treatments, and cures. Advocacy, Patient Engagment, Rare Diseases, and Public Policy Type: | 15 | 0 | 14 | 61 |
 | DIM ELICIT Empowering LIfe sCiences with Innovative Technologies The DIM ELICIT is the network of innovative technologies for biology in Ile-de-France region. Co-leaded by the Institut Pierre Gilles de Gennes for microfluidics (IPGG) and the Institut Pasteur, the DIM ELICIT has been labeled "Domain Of Main Interest" by the regional council of Ile-de-France for the period 2017-2020. Through calls for proposals, this programme supports Paris region research teams to design breakthrough technologies or to disseminate them for first applications in biology. It stimulates interdisciplinary collaborations between technologists and biologists, as well as partnerships with industries. These technological innovations must have a strong … Type: | 8 | 0 | 8 | 1 |
 | SIRIC BRIO - Bordeaux Recherche Intégrée en Oncologie [Automatic translation follows] Translational research on geriatric oncology, sarcomas and tumor microenvironment + focus on patient involvement (PPI) The SIRIC BRIO aims to offer new operational conditions to cancer research, with the aim of optimizing and accelerating the production of new knowledge and promoting its dissemination and application in cancer care. BRIO's integrated research projects aim to bring together and organize in an integrated manner on a single site, fundamental, clinical, human and social sciences, epidemiology and public health research with the ultimate goal of transferring it to patients, in the form of diagnostic tests, drugs, social or public health … Type: | 4 | 0 | 3 | 1 |
 | La Roche-Posay Laboratoire Dermatologique LIFE-CHANGING SKINCARE PRESCRIBED BY DERMATOLOGISTS At La Roche-Posay, we know skin is a matter of life. While skin issues can scar our lives in more ways than one, healing skin has the power to change lives in more ways than one. Everyday, we drive dermatology forward by joining forces with the medical community. Together, we pioneer new ways to be at the service of people. By bringing together radical efficacy and profound human understanding. By revealing the life impact of skin issues, one study at a time, to broaden the scope of care. By bringing the most advanced dermatological knowledge … | 2 | 1 | 0 | 314 |
 | Science 37 Access More Patients. Enroll Faster. Science 37’s mission is to accelerate clinical research by enabling universal trial access for patients. Through our solutions; the MetasiteTM and Patient Recruitment, we accelerate enrollment by expanding the reach of clinical trials to patients beyond the traditional site and rigorously qualifying patients prior to referring them to a traditional site. Our solutions are powered by a proprietary technology stack with in-house medical and operational experts that enhance quality through standardized workflows and best-in-class study orchestration. Patient Recruitment, Patient Qualification, Clinical Trial Enrollment, Clinical Trial Access, Site Conduct, Virtual Site, Hybrid Clinical Trials, Remote Clinical … Type: | 5 | 0 | 4 | 331 |
 | Boundless Bio Unbound by convention, bound to save lives Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence. When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes, driving cancer cells to grow and allowing them to resist treatment. At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive. Our Culture: At Boundless, you’ll … Type: | 3 | 0 | 1 | 83 |
 | Mitsubishi Tanabe Pharma America We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, … Type: | 5 | 0 | 2 | 263 |
 | ImmunXperts, a Q2 Solutions Company Your partner in immunology projects! ImmunXperts a Q2 Solutions Company, your partner for what’s next in assay and biomarker development, advanced laboratory testing, and translational immunology. ImmunXperts brings an unrivaled ability to efficiently develop immunogenicity and immuno-oncology in vitro assays – to address both wanted and unwanted immunity for novel modalities. Immunogenicity Assessment, Immune Academy, Training, Consultancy, immuno-oncology, Cell Therapy, In vitro, assay development, Primary cells, Immunogenicity, and Immunology Type: | 1 | 0 | 0 | 24 |
 | TG Therapeutics, Inc. TG is a biopharmaceutical company focused on the development of novel treatments for B-cell diseases. TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS). Biotechnology, hematological malignancies, non-Hodgkin's lymphoma, multiple sclerosis, b-cell diseases, ublituximab, and umbralisib Type: | 0 | 0 | 0 | 384 |
 | Replimune Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease. | 2 | 0 | 1 | 342 |
 | 3Brain AG We empower researchers to explore intelligent biological networks by linking them to information technology. 3Brain developed and distributes the world’s first commercial CMOS-based high-resolution Microelectrode Array (MEA), a Biosensor integrating thousands of tiny electrical sensors in a small area. Our Biosensor allows non-invasive (in vitro) investigations of electrogenic cells, such as neurons, cardiac and muscle cells. The technology can be used to investigate electroactive cells' fundamental properties (e.g., neural code for learning and memory), to study and find new treatments to different types of diseases (e.g. Alzheimer and epilepsy) and to assess compounds/chemical toxicity. Microelectrode Arrays, High Resolution Electrophysiology, Electrophysiology … Type: | 1 | 0 | 1 | 54 |
 | Nagi Bioscience in vivo testing at the in vitro scale Nagi Bioscience is a pioneering high-tech startup developing NextGen laboratory equipment to unlock the full potential of alternatives to animal testing. Located in the heart of the Swiss "Health Valley”, we work for the transformation of biological testing standards providing cutting-edge equipment to achieve faster, scalable, more efficient and ethical methods. Under the motto “in vivo testing at the in vitro scale”, our technologies are accelerating drug development pipelines and introducing new toxicology testing standards revolutionizing pharmaceutical, cosmetic, and agro-chemical industries among others. Our approach? To unlock the full potential of small … Type: | 3 | 2 | 2 | 29 |
 | AgroSustain SA AgroSustain – a one-stop-shop solution for biological plant protection. AgroSustain – a one-stop-shop solution for biological plant protection. We aim to reduce food waste and support organic food production by developing farm to fork solutions, like biological fungicides and coatings. AgroSustain has developed a pipeline of plant-derived antifungal compounds against broad range of agronomically important fungal pathogens present in pre- (in the field) and post-harvest (in storage). AgroSustain’s first product, called AgroShelf+, extends shelf life of vegetables & fruits infected with mostly spread molds. AgroSustain’s B2B customers, food distributors & producers with post-harvest storage facilities, that value more the effectiveness … Type: | 10 | 5 | 2 | 10 |
 | TRON-Mainz Science in Translation - We put inspiration into practice, finding viable solutions to complex challenges. Our mission is to turn scientific breakthroughs into progress for patients. TRON is a non-profit research institute that pursues new diagnostics and drugs for the treatment of cancer and other diseases with a high medical need. We aim to bridge the gap between fundamental science at universities and market-oriented research in the pharmaceutical industry. We turn innovative scientific concepts into treatments ready for clinical testing, thereby accelerating the translation of discoveries into new diagnostics and therapies for patients. We focus our transdisciplinary competencies in genomics … Type: | 2 | 0 | 2 | 165 |
 | Iconthin Biotech The full-service specialist for algae-based health products. Home of AstaDaily®, AstaDermal®, AlgaeAstaTM and AlgaeO3. Iconthin Biotech, a specialist in Algae-Based Ingredients, is dedicated to pioneering sustainable biotechnology. Our focus extends from enterprise services to the development of consumer-facing products, including nutraceuticals, skincare, and functional foods. At the core of our cutting-edge technology is our commitment to innovation, underscored by our partnership with the renowned microalgae research team at the University of Toronto. We proudly introduce AlgaeAstaTM - Leading with Natural Astaxanthin. Discover the power of AlgaeAstaTM Astaxanthin, derived 100% from the microalgae Haematococcus pluvialis using the latest 3rd generation cultivation … Type: | 11 | 0 | 11 | 6 |
 | Sonata Therapeutics Sonata Therapeutics is a new, Boston-based Flagship Pioneering company revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through our pioneering science, we identify new targets for therapeutics that induce the release of a programmed diversity of signals with the potential for significant patient impact. Our employees are exceptionally passionate, accountable, collaborative, and innovative. Sonata Therapeutics was founded by Flagship Pioneering, an organization dedicated to the origination and development of first-in-category life sciences … Type: | 7 | 0 | 7 | 44 |
 | Intravacc Innovating vaccines to reduce human diseases. Part of Utrecht Science Park Bilthoven Even the most promising vaccines don’t always make it out of the laboratory into large-scale production. We at Intravacc are fully aware of the challenges on the long road of vaccine development. We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies. As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials … Type: | 2 | 0 | 0 | 63 |
 | Arvinas Leading the way in targeted protein degradation therapeutics Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting estrogen receptor for patients with locally advanced or … Type: | 4 | 0 | 2 | 444 |
 | Kymab Ltd Kymab, a Sanofi company, based in Cambridge UK, is working to provide novel solutions in drug and vaccine development. Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available. Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with … Type: | 4 | 1 | 0 | 39 |
 | UNIVERCELLS For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. We are biotech innovators. We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit. Biotechnology, mRNA, CDMO, and Services Type: | 4 | 1 | 3 | 176 |
 | Airfinity Ltd The disease forecasting company, helping you track, predict, and simulate to achieve better disease outcomes. Airfinity tracks, simulates, and predicts population level disease outcomes in real time to inform decisions that can increase the global life span. Specialising in infectious diseases, Airfinity works with the entire life science ecosystem. Our suite of proprietary surveillance tools and forecast models analyse and predict disease outcomes. Spanning over 150 viral, bacterial and fungal pathogens, we use advanced meta science, statistics, epidemiology and machine learning solutions to dynamically understand true disease prevalence and underlying outcome drivers. By combining this with expert analysis and commentary … Type: | 18 | 0 | 18 | 98 |
 | IgniteData Shaping the Future of Clinical Trial Data IgniteData’s Archer technology is transforming the way hospitals and research sites transfer data for clinical trials. EHR-to-EDC data transfer provides fast, accurate patient data for clinical studies, significantly reducing the requirement for laborious data transcription and source data verification (SDV). pharmaceutical, NHS, Electronic Health Records, healthcare data, Clinical Research, Clinical Trials, Clinical Studies, Site Data Verification, biopharma, biopharmaceutical, EHR, EMR, EHR2EDC, interoperability, DigiHealth, medtech, software, life science, healthcare, eClinical, and TrialTech Type: | 5 | 0 | 4 | 19 |
 | ReCode Therapeutics Powering the next wave of genetic medicines through superior delivery ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. RNA Therapies, Genetic Medicines, Non-Viral Lipid Nanoparticles, Genetic Respiratory Disease, Cystic Fibrosis, Primary Ciliary Dyskinesia, and Biotechnology Type: | 4 | 1 | 4 | 120 |
 | BioCentriq Manufacturing Partner for Cell Therapy Process Development and Clinical Production BioCentriq is an established, highly collaborative, global cell therapy CDMO. The company has been successfully manufacturing drug products for use in human clinical trials since 2022. In June of 2023, BioCentriq launched its LEAPTM Advanced Therapy Platform which helps cell therapy developers move from contract to clinic in as short as six months. With industry recognized scientists, engineers, analysts, and manufacturing specialists, established quality systems and modern infrastructure, BioCentriq is a proven strategic partner for the development and manufacturing of both autologous and allogeneic cell therapy products. The company was … Type: | 2 | 0 | 1 | 58 |
 | Century Therapeutics, Inc Harnessing the power of adult stem cells to develop curative therapies for cancer and autoimmune diseases Our genetically engineered, iPSC-derived cell products are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of … Type: | 2 | 0 | 0 | 182 |
 |  Gyroscope Therapeutics Vision for Life: Developing gene therapies and delivery technologies for eye diseases. About Gyroscope Therapeutics, a Novartis company: Gyroscope Therapeutics is a clinical-stage gene therapy company developing gene therapy beyond rare disease to treat diseases of the eye that cause vision loss and blindness. The company was acquired by Novartis, a leading global medicines company, in February 2022. Gyroscope’s lead investigational gene therapy, GT005, is currently being evaluated in Phase II clinical trials for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness. GT005 has received Fast Track designation from the U.S. … Type: | 1 | 1 | 0 | 49 |
 | ZEOFORM Zeoform Micro PulpTM is the world's most sustainable material, made from the world's most renewable resource. Zeoform Micro Pulp uses the world's most renewable resource to make the world's most sustainable material. Whether you want to grow your business, refresh your supply chain, enter a new market or de-risk your product portfolio. Take your business from where you are now to where you want to be. Type: | 2 | 1 | 1 | 8 |
 | Velocity Clinical Research, Inc. Delivering high-quality clinical trial data and patient care with unprecedented efficiency. Velocity is the world’s leading organization of fully integrated clinical research sites. With 90 sites and more than 220 investigators, Velocity partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, diagnostics, and combination products that could improve human health and wellbeing. Velocity offers unified research site solutions to efficiently provide the right patients, investigators, and research staff for clinical trials across the U.S. and Europe. The company also operates a technology hub in India, where it is unlocking a new era in clinical research by developing … Type: | 6 | 0 | 6 | 1,011 |
 | OxSonics Therapeutics Tackling the toughest cancers. We’re OxSonics, a pioneering clinical-stage therapeutics company committed to developing a ground-breaking platform technology to make anti-cancer drugs smarter, act faster and, above all, work better. Our SonoTran® Platform has been designed to actively enhance the delivery of oncology drugs into solid tumours. SonoTran® is drug agnostic and requires no drug reformulation enabling its use with both existing and novel therapies. We have our own development programs as well as collaborations with Pharmaceutical and biotech companies to work to bring smarter, faster and better therapies to as many patient groups as possible. Drug Delivery, Oncology, Medical … Type: | 1 | 0 | 0 | 18 |
 | Oxford Cancer Biomarkers Pioneering Precision Medicine Oxford Cancer Biomarkers translates ground-breaking scientific discovery into predictive biomarker diagnostic products that allow medicines to be personalised for the benefit of the cancer patient. Oxford Cancer Biomarkers is a spin-out of the University of Oxford and has strong links with the Medical Sciences Division in Oxford University. The company was founded by Nick La Thangue, Ph.D., Chair of Cancer Biology at Oxford University and David Kerr, CBE, D.Sc., M.D. FMedSci, Professor of Cancer Medicine at Oxford University. Investors in OCB include Longwall Venture Partners LLP, Esperante BV, Ningbo My-BioMed Biotechnology Co.,Ltd., CancerRop Co. Ltd., and the … | 2 | 0 | 0 | 8 |
 | Kyowa Kirin, Inc.- U.S. Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives. Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes offices in Princeton, NJ; Toronto, Canada and a research facility in La Jolla, CA. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth … Type: | 3 | 0 | 3 | 683 |
 | Albireo Pharma, Inc. On March 2, 2023, Albireo was acquired by Ipsen, strengthening Ipsen’s rare disease portfolio with promising therapeutics for pediatric and adult rare liver diseases. Albireo Pharma is a rare disease company focused on the development of novel bile acid modulators to treat pediatric and adult liver diseases. Albireo’s lead product, Bylvay, was approved by the U.S. FDA as the first drug for the treatment of pruritus in all types of progressive familial intrahepatic cholestasis (PFIC), and in Europe for the treatment of PFIC. Bylvay is also being developed to treat other rare pediatric cholestatic liver diseases with a completed Phase … Type: | 2 | 2 | 1 | 106 |
 | Adan Medical Innovation Improving anaphylaxis management Adan Medical Innovation is a company focused on the improvement of the quality of life of patients that suffer from anaphylaxis, a severe allergic reaction. To achieve this, we have formed a group of experts in different fields (physicians specialized in Allergy and Internal Medicine, business development, patent and regulatory health technologies issues, engineers, information technologies), even including patients among us, and we are working together to offer the best solutions for these patients. The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays two different products in its pipeline: AnAPPhylaxis, a … Type: | 9 | 2 | 5 | 5 |
 | TriSalus Life Sciences An immunotherapy company working to improve the lives of patients living with liver and pancreatic tumors TriSalus Life Sciences is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors. Type: | 0 | 0 | 0 | 116 |
 | OMass Therapeutics OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Science Enterprises. Type: | 13 | 3 | 5 | 80 |
 | Shorla Oncology At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. At Shorla Oncology we develop and commercialize innovative oncology drugs. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments. Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical … Type: | 8 | 2 | 5 | 33 |
 | SiriusXT Whole-Cell Nano-Tomography SiriusXT has developed and manufactures a soft x-ray microscope (the SXT system), which is marketed primarily to researchers working in disease research and drug discovery. The core technology, underpinning the SiriusXT microscope is a vacuum-based laser-produced plasma (LPP) soft x-ray light source. Soft x-ray tomography is essentially a CT scan of the cell, and is critical to life scientists looking to image the 3D internal structure of an entire cell in its native fully hydrated state. The SXT system is used by disease researchers, pharmaceutical companies, bio-technologists and clinicians to aid the understanding of disease pathways, protein-drug interactions … Type: | 0 | 0 | 0 | 27 |
 | Ostoform The New Standard. Ostoform addresses ostomy challenges with its groundbreaking FLOWASSIST technology, redirecting output to minimize leaks, enhancing skin health, and reducing care costs. Born from a commitment to improve life for ostomates, Ostoform is dedicated to setting a new standard in stoma care through empowering breakthrough solutions. Ostomy, Stoma Care, Ostomy Appliances, Manufacturer, Medical Device Manufacturer, Medical Device, Ostomy Barrier Ring, Ostomy Seal, Ostomy Pouches, and Ostomy Care Type: | 1 | 1 | 0 | 20 |
 | Daré Bioscience, Inc. Daring to be different Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class women’s health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women. Vaginal drug delivery is often the optimum delivery approach to achieve these objectives, and IVR technology has become one of our preferred investigational platforms. Our portfolio features innovative IVR technologies including our non-hormonal contraceptive Ovaprene®, which we believe has the potential to disrupt … Type: | 6 | 0 | 5 | 26 |
 | AOA Dx Revolutionizing early diagnosis of Ovarian Cancer AOA Dx is developing the next frontier in early-stage cancer detection for women through its pioneering work in glycolipids and proprietary biomarker technology. Our revolutionary tumor marker ganglioside platform, GlycoLocateTM, is paving the way for life-saving early cancer detection. In a first of its kind, AOA Dx is developing AKRIVIS GDTM, an early-stage liquid biopsy test for ovarian cancer, that has proven excellent sensitivity and specificity in a recent study. We foresee novel tumor biomarker gangliosides as the future for diagnosis, prognosis, monitoring, and eventually targeted therapies across multiple cancers. AOA Dx was co-founded … Type: | 6 | 0 | 6 | 37 |
 | BioMin Technologies Limited A patented bioactive material for treating dentine hypersensitivity and providing additonal protection from tooth decay. BioMin Technologies Ltd was established in 2014 to commercialize research from Queen Mary University London and Imperial College, London. We specialise in the development of bioactive glass materials for treating dentine hypersensitivity and providing additonal protection from tooth decay. BioMin’s technology is based on three core patent applications that enable the slow release of Fluoride, Calcium and Phosphate ions that enable the formation of Fluorapatite and as such outperform equivalent products on the market. This has numerous dental applications, from toothpaste and composites, to orthodontic … Type: | 1 | 1 | 0 | 12 |
 | Onalabs Inno-Hub The future of biomonitoring Point-of-Care (POC) technologies, designed to provide rapid clinical diagnosis at, or near the site of patient care, has the potential to sense changes in well-known biomarkers used already to monitor patients with chronic cardiac and respiratory diseases. However, they need to be measured in blood, which limit their use only in medical institutions. Our non-invasive products based on wearable formats will empower the patients and their families to measure relevant biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier (self-)management strategies, resulting in shorter … Type: | 9 | 2 | 7 | 22 |
 | BDI biotech BDI biotech provides biotechnological services and solutions in the Cosmetics, Agro, Food and Industrial fields. At BDI biotech we provide biotechnological services and solutions in the Cosmetics, Agro, Food and Industrial fields to bring ideas from bench to reality. We works as an external R&D department specialized in strain and bioprocess development (production, recovery and/or its application), scale-up and regular batches productions. Our Services: 1) Strain Selection & Improvement. Whether it's yeast, fungi, or bacteria, we provide the tools and services to increase byproduct or biomass production. 2) BioProcess Development & Scale-Up: BDI biotech has strong expertise in bioprocesses optimization, … | 1 | 0 | 1 | 46 |
 | HiberGene Diagnostics Saving Time, Saving Life. HiberGene Diagnostics is a Dublin-based, private Irish company, that develops, manufactures and markets molecular diagnostic tests for the direct detection of human infectious diseases, using the LAMP (Loop Mediated Isothermal Amplification) technology. In May 2020, HiberGene successfully completed the CE marking of a new fast molecular COVID-19 test. The new COVID-19 test, which expands the company’s product range to 13 tests. Positive results are returned within a few hours, enabling rapid diagnosis of the disease at the early and highly infectious stage of infection. With its expanding HG product line, HiberGene is committed to providing rapid … Type: | 2 | 0 | 2 | 8 |
 | KetoSwiss AG Fuel for brains. KetoSwiss is a Swiss biotechnology company located in Basel, that develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolic dysfunction (such as Alzheimer's disease). The lead product’s active substance is an endogenous metabolite – a Ketone body, that can be used by the human brain as an alternative source of fuel to glucose, when glucose utilization or transport is compromised. Migraine, Alzheimer's, Neuroscience, Medical Food, Biotechnology, Mental Health, Ketones, Supplements, and Novel Food Type: | 1 | 0 | 1 | 8 |
 | Perfect Day Complete whey protein, made more sustainably. We’re rethinking everything. Starting with food. Using safe, proven fermentation methods we make animal-free whey protein from microflora – not cows – to make dairy that’s identical to traditional milk. The production of our whey protein emits up to 97% less greenhouse gas emissions, uses up to 99% less blue water, and uses up to 60% less nonrenewable energy, compared to the production of protein found in traditional milk. Our protein comes in a variety of applications including cream cheese, barista milk, ice cream, protein powder, egg replacer, bakery mix, confectionery, and gelato. Some … Type: | 25 | 5 | 21 | 302 |
 | Bitbrain High-tech EEG brain sensing devices & software solutions for human behaviour research, health and neurotech development. Bitbrain was founded in 2010 as a spin-off company of a research team from the University of Zaragoza, pioneer in approaching brain-computer interface applications outside laboratory investigation settings. Its DNA holds all knowledge in neurotechnology, biomedical engineering, artificial intelligence and data science accumulated at the university since 1998. Nowadays, the R+D+I bet is still strong, which has converted the company in a world reference for B2B neurotechnology solutions. Neurotecnología, Investigación y Desarrollo, Decodificaciones complejas de señales fisiológicas, and Neuromarketing Type: | 14 | 1 | 10 | 62 |
 | Artus Therapeutics Sealing The Broken Barrier Currently we are not hiring. Please beware of scammers Artus is a pre-clinical stage company developing first-in-class therapeutics for inflammatory and metabolic diseases by targeting barrier dysfunction. Type: | 1 | 1 | 0 | 3 |
 | Provention Bio, a Sanofi Company Provention Bio is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated diseases. At Provention Bio, we approach autoimmune disease differently than traditional pharma, with a clear focus on early interception. Before symptoms present, before irreversible damage is done to the bodies, minds, and lives of patients and families, and before it’s too late —this is where we operate. Our lead investigational product candidate is currently under review by the U.S. Food and Drug Administration (FDA) for the delay or prevention of clinical type 1 diabetes in at-risk individuals. … Type: | 1 | 1 | 1 | 76 |
 | GENZ Biotechnology Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik … Type: | 0 | 0 | 0 | 3 |
 | Molecular Attraction AB New Way of VECTOR CONTROL Molecular Attraction technology enable development of vector-diseases control and eradication strategies. We are a bio-attractant discovery company. We identify biological compounds which can change behaviour of vectors organisms like mosquitoes, flies or rodents. Molecular Attraction compounds includes: Volatile attractants Phagostimulants Pheromones Molecular Attraction is a biotechnology company anchored in high-end research stemming from Stockholm University. Our competence: Biochemical compound identification Insect behaviour Parasitic infections biochemistry and immunology vector control, malaria, dengue, mosquitoes, vector diseases, pest control, and sustainability | 3 | 0 | 3 | 13 |
 | Oxurion NV Advancing Science. Enhancing Vision Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel therapeutic for the treatment of DME. THR-149 is a potent plasma kallikrein inhibitor being developed as a potential new standard of care for the up to … Type: | 0 | 0 | 0 | 34 |
Startup